Hints and tips:
...Since signing up to the DNA-testing, ancestry-mapping service 23andMe in 2014, she has found 93 — and counting....
...Garage scientists’ DNA gamble The growing accessibility of gene-editing tools has led to an explosion of unchecked experimentation in biological self-improvement in recent years....
...He is unforthcoming about his biological father, who is dead. “I didn’t know him very well.”...
...The FDA permitted Biogen to market aducanumab, the first drug designed to treat an underlying biological cause of Alzheimer’s disease, in the face of considerable scientific doubts about its clinical effectiveness...
...“And instead tragically it is a biological one, so everybody is locked up and we had the greatest growth in the first half of this year that we ever had.”...
...If we are successful, global trade rules may have to be rewritten to properly value the nature-inspired assets and services in developing countries....
...According to Japan’s Fermata Inc, which provides services to femtech start-ups, there were 318 companies focused on women’s health worldwide in March 2020, up from 221 in 2019 and 50 in 2017....
...BlackRock is listing each ETF’s exposure to cluster munitions, landmines, depleted uranium, biological and chemical weapons, nuclear weapons, civilian firearms producers and tobacco producers....
...Europe is ahead of the rest of the world in adoption of biosimilars, and the UK’s taxpayer-funded National Health Service is in the vanguard, having already shifted 80 per cent of eligible patients on to...
...The debate on how Britain's National Health Service should be financed shows no sign of letting up....
...For Brian Carroll, a New York-based partner at PwC who participates in the professional service company’s baseball competition, sport is a chance to meet people from unfamiliar parts of the firm....
...The UK’s National Health Service pays about $2 for the equivalent product....
...Parts of his memo claimed that women were less well suited to be engineers and leaders for biological reasons....
...The next batch of drugs set to lose their patents are “biological” medicines harvested from living cells, rather than easy-to-copy pills....
...“It’s a miserable way to make a profit and does nothing to restore public trust in the financial services industry,” said Catherine Howarth, chief executive of the organisation....
...Some countries want to use private services to achieve universal health coverage. Others use public services only. Yet others use a mix of private and public....
...Oxford Nanopore Technologies The UK company aims to enable biological analysis of any living thing by anyone anywhere....
...Samsung C&T and Samsung Electronics are the two major shareholders in the maker of biological medicines, with the latter set to sell 5.5m shares....
...Local media reports and the anger of online users have focused on the influence of the “Putian network” in driving unethical behaviour in marketing of medical services....
...But, while traditional chemical-based pills can be copied identically, modern biological therapies are harder to replicate....
...Britain’s National Health Service has this year cut access to several cancer drugs deemed insufficiently cost-effective in order to rein in spending....
...The labour force is already feeling the impact of automation, and more than a third of UK jobs are at risk of disappearing in the next 20 years, according to research from Deloitte, the professional services...
...They say the rise of biosimilars — cheaper copycat versions of modern biological drugs — will help control costs as the previous wave of blockbuster cancer therapies from a decade ago, such as Novartis’s...
...Before a treatment is recommended for use in Britain’s National Health Service, its manufacturer must convince Nice that the product represents value for money....
...Selling more high-priced, high-margin drugs has left a hole to be filled, with generic competition escalating and health services balking at the bill....
International Edition